Nyxoah SA at Oppenheimer Healthcare Conference (Virtual) Transcript
Good morning, everyone. This is Suraj Kalia. I'm the senior medical device analyst at Oppenheimer. Pleased to have all of you join us this morning, the second day of the Oppenheimer Annual Healthcare Conference. I am truly pleased to have a unique company start off the day on our side, which is Nyxoah. They are doing some very interesting stuff in obstructive sleep apnea, and I'll let the company talk about it.
Presenting this morning are Olivier Taelman, CEO. Olivier, it's a pleasure to have you. I'll let you take the floor from here.
Okay. Thank you, Suraj, and thank you to the Oppenheimer team for having us and allowing us to share the Nyxoah story. So -- sorry we are -- so maybe I should start with a brief introduction of myself and also Fabian Suarez, our CFO.
So I'm Olivier Taelman, I'm born and raised in Belgium. I spent more than 20 years in the med tech industry, of which almost 10 years
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |